Ranbaxy puts generic Zyprexa on Spanish market on day one of patent expiry
This article was originally published in Scrip
Executive Summary
Ranbaxy Laboratories has launched 2.5mg, 5mg, 7.5mg and 10mg tablet generic versions of Lilly's atypical antipsychotic Zyprexa (olanzapine) in Spain, on the first day following the local patent expiry for the innovator product.